retatrutide triple agonist obesity trial glp-1 gip glucagon phase 2 Ozempic targets one receptor. Tirzepatide Weight loss with retatrutide as

Y.RejS.SuissaS.AzoulayL

doi: 10.3390/jcdd5010018 53 BurmeisterMAFerreTAyalaJEKingEMHoltRMAyalaJE

Retatrutide has demonstrated exceptional weight loss results in clinical trials

The Phase 2 trial (338 adults, 48 weeks) was published in the New England Journal of Medicine

This is the longest fasting period most people experience daily, and it creates ideal conditions for sublingual absorption

There are a lot of people out there that could probably lose weight without GLP-1 drugs if they just discipline themselves and exercise more, but there is a segment of the population that cannot lose weight, and my daughter Alexa unfortunately falls within that category, Rich said